FUJIY posts record Q2 revenue and profit, fueled by strength in Healthcare, Imaging, and Electronics, prompting a revenue forecast upgrade.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Fujifilm (FUJIY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
CNBC's Angelica Peebles joins 'Money Movers' with a look at Fujifilm's new drug manufacturing plant in North Carolina.
FUJIY posts modest Q1 revenue growth on strength in Bio CDMO and Imaging, despite FX losses hitting net income.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
FUJIFILM Holdings Corporation (OTCPK:FUJIY) Q1 2026 Earnings Conference Call August 6, 2025 2:10 AM ET Company Participants Chisato Yoshizawa - Corporate VP, GM of Corp Communications and ESG Division- Global Audit Dep, Brand Mgmt & Director Masayuki Higuchi - Corporate VP, GM of Corporate Planning Division, Accounting and Finance Div, CFO & Director Nagasawa - Corporate Participant Naoki Hama - Director Teiichi Goto - President, CEO & Director Tetsuya Iwasaki - Corporate Participant Toshihisa Iida - Corporate Participant Conference Call Participants Masahiro Nakanomyo - Jefferies LLC, Research Division Masahiro Shibano - Citigroup Inc., Research Division Mie Yamazaki - Unidentified Company Seiji Wakao - JPMorgan Chase & Co, Research Division Shinnosuke Tokumoto - SMBC Nikko Securities Inc., Research Division Yu Okazaki - Nomura Securities Co. Ltd., Research Division Nagasawa It is now the scheduled time.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Fujifilm delivered strong FY2025 results, driven by progress on VISION2030 and diversified business mix. Electronics and Imaging excelled, while Healthcare remains a key growth focus with major contract wins in biomanufacturing. Valuation is attractive after a recent pullback, with a 30% upside consensus target.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.